Reuters logo
BRIEF-Glaxosmithkline submits EU filing for Relvar Ellipta extension
July 21, 2017 / 1:07 PM / 2 months ago

BRIEF-Glaxosmithkline submits EU filing for Relvar Ellipta extension

July 21 (Reuters) - Glaxosmithkline Plc:

* Submits EU filing for extended use of Relvar Ellipta in patients with controlled asthma on an ICS/LABA combination Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below